Zurueck zur Suche

Reporte zur Charge U006485

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

23Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 6 VA 2 DC 2 NC 2 VT 1 MA 1 LA 1 NE 1 GA 1 IL 1 MI 1 CT 1

VAERS 2620173

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

mild
Staat
VT
Alter
-
Geschlecht
M
Eingang
24.04.2023
Impfdatum
16.02.2023
Beginn
13.03.2023
Tage bis Beginn
25,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

The caller was patient's mother. The caller stated that her son received the MMR II vaccine 16FEB2023 and now has a rash all over his face , arms, legs, and lower back.; The caller was patient's mother. The caller stated that her son received the MMR II vaccine 16FEB2023 and now has a rash all over his face , arms, legs, and lower back.; This spontaneous report has been received from a consumer concerning her son of a 13-month-old male patient. His concurrent conditions, medical history, and concomitant therapies were not reported. On 16-FEB-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection 0.5 ml (strength, dose, route of administration were not provided; lot# U006485 and expiration date) for prophylaxis. On 13-MAR-2023, the patient had a rash all over his face, arms, legs, and lower back, and the provider stated it looked like Rubella rash. Besides, the provider thought it was from the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) vaccine. The provider did not know how long it would take the rash to go away. At the time of this report, the outcome of the events was not reported. The action taken regarding the events with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was not applicable. The causality between the events and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278158

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u006485

mild
Staat
TX
Alter
1,1
Geschlecht
F
Eingang
16.05.2022
Impfdatum
31.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site induration

Symptomtext

Reports leg redness and hardness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Viral illness
Vorgeschichte
N/A
Andere Medikamente
None known
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2241115

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

mild
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
11.04.2022
Beginn
13.04.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Gait disturbance Sacral pain

Symptomtext

Pt. reports that she developed tailbone/sacral pain around 8 am on 4/13 after having received MMR vaccine at 0952 on 4/11/ 22 Pain progressively worsened and is making it difficult for her to walk. Pt. did not report her side effects to employee health clinic until 04/19/22. She was advised to not receive any further MMR vaccinations and to consult with her Health care professional ASAP Upon investigation, pt. states that when she came to the country in 2016, she was given about 7 immunizations together and had a similar reaction, but did not know which had caused it. Pt. denied any issues with MMR vaccine at the time that it was administered and only had listed Hep B vaccine and Augmentin as allergies.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Sacral pain
Hospital-Tage
-
Labordaten
None as yet. Pt. is following up with her medical professional
Aktuelle Erkrankungen
NA
Vorgeschichte
Cornea Cross linking
Andere Medikamente
ditropan
Allergien
Hep B vaccine, Augmentin
Vorherige Impfungen
-

VAERS 2184254

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

mild
Staat
TX
Alter
1,0
Geschlecht
M
Eingang
17.03.2022
Impfdatum
10.03.2022
Beginn
15.03.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Irritability Pain Swelling

Symptomtext

I received alarm on baby's diary because he is doing the study, but reaction was on NON-IP thigh, right side, located where my PI injected the MMR vaccine, the Varicella Zoster vaccine was injected lower on the thigh area, mom reported mild irritibility to 3, moderate pain to 5 and severe swelling to 15, mom gave Tylenol that night, the next morning when I assessed the situation, mom sent photo to clinic, I reported to my PI, Dr. , my monitor and submitted Adverse Event to the study on NON-IP reaction form in system.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
only Tylenol
Allergien
none
Vorherige Impfungen
-

VAERS 2157585

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

mild
Staat
MA
Alter
3,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
26.02.2022
Beginn
26.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Patient broke out in full body rash around 1:45PM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
2/22/22 cough and congestion
Vorgeschichte
asthma
Andere Medikamente
unknown
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2036158

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

mild
Staat
LA
Alter
1,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis diaper Rash Rash macular

Symptomtext

After patient awoke from daily nap, noted to have macular erythematous flat rash mostly on trunk, a little on extremities, diaper area also. No respiratory distress, no wheeze, no swelling of mucosal membranes, no scrotal swelling, no vomiting or diarrhea. Pulse ox was 97%.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Dad was COVID positive about 3 weeks prior, but patient tested negative. He had symptoms of cough and runny nose and mild fever.
Vorgeschichte
Eczema
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2645348

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
VA
Alter
11,0
Geschlecht
U
Eingang
14.06.2023
Impfdatum
01.03.2023
Beginn
01.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine administered that expired 2/26/2023, Merck notified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637492

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
-
Alter
54,0
Geschlecht
U
Eingang
26.05.2023
Impfdatum
16.05.2023
Beginn
16.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; HCP called to report inadvertent administration of an expired dose of MMR II. No adverse effects reported. MMR II expired 2/26/2023 and patient was administered the vaccine today, 5/16/2023. HCP also asked about the need for revaccination. Post E; This spontaneous report as received from a nurse referring to a 54-year-old patient of unreported gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported. On 16-MAY-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number U006485, expiration date 26-FEB-2023, 0.5 milliliter (route of administration not reported) for prophylaxis (expired product administered). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2598873

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
18.03.2023
Impfdatum
01.03.2023
Beginn
01.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; expired MMRII on 03/01/2023; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 01-MAR-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) subcutaneous injection (lot#: U006485, expiration date: 26-FEB-2023; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2568879

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
NE
Alter
-
Geschlecht
U
Eingang
26.01.2023
Impfdatum
12.12.2022
Beginn
12.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; HCP reporting an expired dose of STERILE DILUENT was administered to a patient. Caller stated the dose of STERILE DILUENT was used to reconstitute a dose of MMR II (which was not expired) was administered on 12-DEC-2022; This spontaneous report was received from a nurse and refers to a patient of an unknown age or gender. The patient's medical history, concurrent, concomitant therapies and previous drugs reactions or allergies were not reported. On 12-DEC-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) dose given per the prescribing information, lot #U006485, expiration date: 26-FEB-2023, administered for prophylaxis (strength, and route of administration were not provided) reconstitute with an expired sterile diluent (MERCK STERILE DILUENT) dose given per the prescribing information, lot #U031356, expiration date: 23-NOV-2022 (Expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Medication dilution
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464123

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
DC
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

Vaccine given in error; No adverse reaction to vaccine; This non-serious case was received during the Reporting System monitoring on 12-JUL-2022 with the following Primary ID 2307076-1. The original narrative from the sender is the following: Vaccine given in error. Order was for Varicella (Varivax) which was misread and Dtap IPV HIb HepB (Vaxelis) administered. Pt had no adverse reaction to vaccine and will receive correct vaccine during 15 month well child check. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Vaccine given in error". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412977

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
-
Beginn
20.07.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse event; Caller is medical assistant reporting administered doses of improperly stored vaccines; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot # U006485, has been verified to be a valid lot number for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [rHA] [M-M-R II], expiration date reported and upon internal validation established as 26-FEB-2023) (dose, anatomical location, route of administration, lot#, and expiration date were not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U002400, has been verified to be a valid lot number for varicella virus vaccine live [oka/merck] [VARIVAX], expiration date reported and upon internal validation established as 22-JAN-2023) (dose, anatomical location, route of administration, lot#, and expiration date were not reported). Both vaccine doses were given as prophylaxis and were improperly stored (Product storage error) on 20-JUL-2022 as following: measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II): Above 8 Celsius degrees (?C) (8.8C) for 1 hour 27 minutes and 0 seconds; above 8C (8.5C) for 6 hours 39 minutes and 0 seconds; above 8C (8.8C) for 8 hours 45 minutes and 0 seconds; above 8C (10.7C) for 11 hours 42 minutes and 0 seconds; above 8C (9.83C) for 18 hours 48 minutes and 0 seconds; above 8C (9.5C) for 14 hours 10 minutes and 0 seconds; above 8C (9.0C) for 9 hours 24 minutes and 0 seconds and varicella virus vaccine live (oka/merck) (VARIVAX) at a temperature of -14?C up to -10?C (-13.1C) for 18 minutes and -14?C up to -10?C (-11.9C) for 21 minutes. The vaccines did not have previous temperature excursions. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2411944

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
16.08.2022
Impfdatum
-
Beginn
30.06.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional adverse events; administered doses of improperly stored vaccines; This spontaneous report has been received from a medical assistant, referring a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were not provided. On 30-JUN-2022, the patient was vaccinated with 1 improperly stored dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) (lot number U006485 has been verified to be a valid lot number, expiry date 26-FEB-2023), and 1 improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U002400 has been verified to be a valid lot number, expiry date 22-JAN-2023) (strengths, doses, frequencies, routes of administration, and anatomical locations were not provided) both vaccines indicated as prophylaxis. The measles, mumps, rubella and varicella (oka merck) virus vaccine live (M-M-R II) was stored at a temperature of above 8 degree Celcius (C) (8.8C) for 1 hour 27 minutes and 0 seconds; above 8 C (8.SC) for 6 hours 39 minutes and 0 seconds, above 8 C (8.8 C) for 8 hours 45 minutes and 0 seconds; above 8 C (10.7C) for 11 hours 42 minutes and 0 seconds; above 8 C (9.83C) for 18 hours 48 minutes and 0 seconds; above 8 C (9.5 C) for 14 hours 10 minutes and 0 seconds, and above 8 C (9.OC) for 9 hours 24 minutes and 0 seconds. The varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored a t a temperature of -14?C up to -10?C (-13.1C) for 18 minutes; and -14?C up to -10?C (-11.9C) for 21 minutes. There was no previous temperature excursion. No additional adverse events were reported. 9.5 Fahrenheit (F) for the time frame of 35 minutes. There was no previous temperature excursion. No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2409339

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
30.06.2022
Beginn
30.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional adverse events; Caller is medical assistant reporting administered doses of improperly stored vaccines; This spontaneous report has been received from a medical assistant concerning to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, a temperature excursion occurred for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), in which the vaccine was at the following temperatures: 8.8 degrees Celsius for 1 hour and 27 minutes, 8.5 degrees Celsius for 6 hours and 39 minutes, 8.8 degrees Celsius for 8 hours and 45 minutes, 10.7 degrees Celsius for 11 hours and 42 minutes, 9.83 degrees Celsius for 18 hours and 48 minutes, 9.5 degrees Celsius for 14 hours and 10 minutes and 9 degrees Celsius for 9 hours and 24 minutes. Also a temperature excursion occurred for varicella virus vaccine live (oka/merck) (VARIVAX), which was at a temperature of -13.1 degrees Celsius for 18 minutes and -11.9 degrees Celsius for 21 minutes (both temperatures were also reported as "-14 to -10 degrees Celsius"). No previous temperature excursions were reported for any of the vaccines. On 30-JUN-2022, the patient was vaccinated with 1 dose of one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) lot # U006485, expiration date 26-FEB-2023 (dose, route of administration and anatomical location were not provided) for prophylaxis and 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U002400, expiration date 22-JAN-2023 (dose, route of administration and anatomical location were not provided) for prophylaxis (product error). No additional events were reported (no adverse event). This is one of multiple reports from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2320137

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
15.06.2022
Impfdatum
13.05.2022
Beginn
13.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; vaccine administered after temperature excursion; Information has been received from an office manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On 13-MAY-2022, the patient received measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) 0.5 ML subcutaneously (SQ) (valid lot# U006485 with expiration date 26-FEB-2023; strength was not reported) for prophylaxis, the vaccine was administered after temperature excursion (8.5 Celsius (C) degree for 4 hours and 20 minutes; no previous temperature excursion)(Product storage error). No additional adverse event was reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2307076

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
DC
Alter
1,2
Geschlecht
F
Eingang
02.06.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Vaccine given in error. Order was for Varicella (Varivax) which was misread and Dtap IPV HIb HepB (Vaxelis) administered. Pt had no adveres reaction to vaccine and will receive correct vaccine during 15 mon well child check.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
none
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2266739

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
IL
Alter
1,2
Geschlecht
M
Eingang
07.05.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AE reported; Nurse called and reported that a 12 month old consumer received VARIVAX on 3/16/2022 and MMR-II today, 4/6/2022; This spontaneous report was received from a registered nurse concerning a 14-month-old male patient. Information regarding the patient's current conditions, medical history and historical drug was not provided. On 16-MAR-2020, patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX.) On 06-APR-2022, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5 milliliters subcutaneous route on the left thigh, lot number U006485 (rHA) expiration date 26-FEB-2023 administered as prophylaxis (Inappropriate schedule of product administration.) No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
VARIVAX
Allergien
-
Vorherige Impfungen
-

VAERS 2239126

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
MI
Alter
1,0
Geschlecht
M
Eingang
18.04.2022
Impfdatum
14.04.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
URI one week prior
Vorgeschichte
no
Andere Medikamente
Albuterol PRN
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2220350

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
CT
Alter
16,0
Geschlecht
M
Eingang
07.04.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Pt received DTAP and should have received TDAP No s/s adverse reaction immediately following, nor 1 week following.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
hypertriglyceridemia, obesity
Andere Medikamente
desloratadine 5mg po qd
Allergien
Zithromax
Vorherige Impfungen
-

VAERS 2203656

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
NC
Alter
1,0
Geschlecht
F
Eingang
29.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; temperature excursion, with subsequent administration; This spontaneous report was received from a healthcare provider and refers to a 1-year-old female patient. There was no information regarding patient's medical history, concurrent conditions and concomitant medications provided. On 21-MAR-2022, during 1-year well check, the patient was vaccinated with improperly stored doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin (rHA)) (M-M-R II) 0.5 milliliter, frequency: once, subcutaneously, lot# U006485, expiration date: 26-FEB-2023 and varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, frequency: once, subcutaneously, lot# U022320, expiration date: 15-JUL-2023, both for prophylaxis(indication also reported as "1-year-well check"). The aforementioned vaccines underwent a temperature excursion of 1 degree Celsius for 7 hours (product storage error) on an unknown date before administration. On an unspecified date, there were multiple previous temperature excursions. There were no lab diagnostic studies performed. The patient did not seek medical attention. No additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2187659

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
PA
Alter
1,2
Geschlecht
F
Eingang
18.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

N/A

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2172586

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
NC
Alter
-
Geschlecht
U
Eingang
11.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE information provided; HBP in charge of vaccine storage calling to report that MMR II and VARIVAX were administered to a patient today 3/4/2022; This spontaneous report was received from an other health professional referring to a 57-week-old patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 04-MAR-2022, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number U006485, expiration date 26-FEB-2023 and varicella virus vaccine live (oka/merck)(VARIVAX) lot number U022320, expiration date 15-JUL-2023 (doses and routes of administration not reported) both for prophylaxis (product storage error). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2155741

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U006485

gering
Staat
WI
Alter
52,0
Geschlecht
M
Eingang
03.03.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration

Symptomtext

Patient was given dose 1 of MMR intramuscularly in the right deltoid muscle instead of subcutaneously.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
Prostate cancer - in remission
Andere Medikamente
Patient does not fill at our pharmacy.
Allergien
NKDA
Vorherige Impfungen
-